Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Landman

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Leukemia & Lymphoma|March 14, 1998
In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemiaM Cavazzana-Calvo, N Jabado, P Bordigoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2008
Mutations in NALP12 cause hereditary periodic fever syndromesI Jéru, P Duquesnoy, T Fernandes-Alnemri, et al.
Leukemia|November 20, 2009
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activityB Gerby, F Armstrong, P B de la Grange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemiaG Michel, J Landman-Parker, M F Auclerc, et al.
The Journal of Clinical Investigation|May 17, 2000
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gammaE Jouanguy, S Dupuis, A Pallier, et al.
BMC Public Health|December 23, 2009
Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2)Leandra J M Boonman-de Winter, Frans H Rutten, Maarten J Cramer, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
Leukemia|January 19, 2000
Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study groupJ Bernstein, N Dastugue, O A Haas, et al.
Blood|October 29, 2021
Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defectsC Dhunputh, S Ducassou, H Fernandes, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Journal of Medical Genetics|April 16, 2009
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotypeE Pasmant, A Sabbagh, N Hanna, et al.
Leukemia & Lymphoma|March 14, 1998
In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemiaM Cavazzana-Calvo, N Jabado, P Bordigoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2008
Mutations in NALP12 cause hereditary periodic fever syndromesI Jéru, P Duquesnoy, T Fernandes-Alnemri, et al.
Leukemia|November 20, 2009
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activityB Gerby, F Armstrong, P B de la Grange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemiaG Michel, J Landman-Parker, M F Auclerc, et al.
The Journal of Clinical Investigation|May 17, 2000
In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gammaE Jouanguy, S Dupuis, A Pallier, et al.
BMC Public Health|December 23, 2009
Early recognition of heart failure in patients with diabetes type 2 in primary care. A prospective diagnostic efficiency study. (UHFO-DM2)Leandra J M Boonman-de Winter, Frans H Rutten, Maarten J Cramer, et al.
Leukemia|August 27, 2005
Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative GroupY Perel, A Auvrignon, T Leblanc, et al.
Leukemia|January 19, 2000
Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study groupJ Bernstein, N Dastugue, O A Haas, et al.
Blood|October 29, 2021
Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defectsC Dhunputh, S Ducassou, H Fernandes, et al.
Pageof 20